The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-(4-(((1,1'-biphenyl)-4-yl)amino)pyrimidin-2-yl)piperazin-1-yl)ethan-1-ol ID: ALA4474234
PubChem CID: 155537019
Max Phase: Preclinical
Molecular Formula: C22H25N5O
Molecular Weight: 375.48
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: OCCN1CCN(c2nccc(Nc3ccc(-c4ccccc4)cc3)n2)CC1
Standard InChI: InChI=1S/C22H25N5O/c28-17-16-26-12-14-27(15-13-26)22-23-11-10-21(25-22)24-20-8-6-19(7-9-20)18-4-2-1-3-5-18/h1-11,28H,12-17H2,(H,23,24,25)
Standard InChI Key: MIGYHYGLNSMSCY-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
14.3572 -5.9638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3561 -6.7833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0641 -7.1923 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.7738 -6.7829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7709 -5.9602 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0623 -5.5549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4821 -7.1904 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0599 -4.7378 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3510 -4.3313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4791 -8.0077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1834 -8.4151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8929 -8.0089 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.8936 -7.1907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1848 -6.7788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5997 -8.4190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3519 -3.5148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6438 -3.1084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9363 -3.5192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9414 -4.3406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6500 -4.7433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2302 -3.1154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2280 -2.2971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5194 -1.8916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8125 -2.3033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8187 -3.1247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5279 -3.5265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3083 -8.0120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0151 -8.4222 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
6 8 1 0
8 9 1 0
7 10 1 0
7 14 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
12 15 1 0
9 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 9 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
18 21 1 0
15 27 1 0
27 28 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 375.48Molecular Weight (Monoisotopic): 375.2059AlogP: 3.00#Rotatable Bonds: 6Polar Surface Area: 64.52Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.09CX LogP: 3.68CX LogD: 3.50Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.69Np Likeness Score: -1.42
References 1. Leal ES, Adler NS, Fernández GA, Gebhard LG, Battini L, Aucar MG, Videla M, Monge ME, Hernández de Los Ríos A, Acosta Dávila JA, Morell ML, Cordo SM, García CC, Gamarnik AV, Cavasotto CN, Bollini M.. (2019) De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus., 182 [PMID:31472473 ] [10.1016/j.ejmech.2019.111628 ] 2. De S, Aamna B, Sahu R, Parida S, Behera SK, Dan AK.. (2022) Seeking heterocyclic scaffolds as antivirals against dengue virus., 240 [PMID:35816877 ] [10.1016/j.ejmech.2022.114576 ]